Healthcare Industry News: Elekta
News Release - April 13, 2012
Elekta to Unveil New Neuroscience Solution for Leksell Gamma Knife at 2012 AANS MeetingMIAMI BEACH, Fla., April 13, 2012 -- (Healthcare Sales & Marketing Network) -- At the 2012 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, April 14-18, at the Miami Beach Convention Center, Elekta (booth #725) will reveal compelling innovations for Leksell Gamma Knife® Perfexion™ that promise to enhance information management.
"Once again, AANS will give us the opportunity to demonstrate to neurological surgeons that Gamma Knife® radiosurgery is a continually evolving technique that makes use of the technological expertise that Elekta has gained over the last 60 years," says Jay Hoey, Executive Vice President, Elekta North America. "The latest example is the capability to exchange information, such as treatment plans, treatment record and protocols, both pre- and post-treatment, putting electronic medical records at your fingertips and allowing you to see all of your treatment statistics in one convenient dashboard. The result is a better flow of patient care and improved use of time and resources."
In addition to the latest product enhancements, Elekta will highlight characteristics of Leksell Gamma Knife Perfexion that separate the system from other radiosurgery solutions. These include its dedication to intracranial cases, complete solution integration, industry-leading accuracy, "shrink-wrap" dose conformity and extensive proven clinical efficacy. Demonstrations of the system will emphasize that Perfexion is designed to minimize the risk of human error and radiation toxicity, while optimizing accuracy and dose conformance.
Other meeting highlights
Elekta also will exhibit several other solutions that improve the management of neurological and neurosurgical cases, including:
Extend™ System for frameless, multi-session hypofractionation Gamma Knife radiosurgery
Elekta Neuromag® TRIUX, the most highly sophisticated magnetoencephalography (MEG) system available
Leksell Stereotactic System® for functional neurosurgery. Exceptional imaging, high platform rigidity and ease of use ensure that critical accuracy requirements are met for this surgical discipline
Leksell SurgiPlan® 10, Elekta's advanced image-based neurosurgical planning software specifically designed for Leksell Stereotactic System®
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.Elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.